Cargando…
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
BACKGROUND: The ACOSOG-Z0011- and the AMAROS-trial obviated the need for axillary surgery in most sentinel node-positive (SLN+) breast cancer patients undergoing breast-conserving surgery (BCS). Data for patients who undergo mastectomy is scarce. The purpose of this study was to investigate patterns...
Autores principales: | Verreck, Eline E. F., van Steenhoven, Julia E. C., Kuijer, Anne, van Maaren, Marissa C., Simons, Janine M., Siesling, Sabine, van Dalen, Thijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409658/ https://www.ncbi.nlm.nih.gov/pubmed/37225832 http://dx.doi.org/10.1245/s10434-023-13568-3 |
Ejemplares similares
-
ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline, et al.
Publicado: (2023) -
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
por: van Steenhoven, Julia E. C., et al.
Publicado: (2022) -
Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020) -
Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature
por: Francissen, Claire M. T. P., et al.
Publicado: (2012) -
The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019)